Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Serum steroids in relation to benign prostatic hyperplasia

P Lagiou¹, C S Mantzoros, A Tzonou

¹Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA.

|December 12, 1997

Summary

Dehydroepiandrosterone sulfate (DHEAS) is linked to an increased risk of benign prostatic hyperplasia (BPH). This study found a significant positive association between DHEAS levels and BPH risk in men.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Mediterranean diet: definitions, health effects and metabolic pathways - evidence and future directions.

Metabolism: clinical and experimental·2026

Same author

Dropout risk and effectiveness of retention strategies in the Memory Advancement by Intranasal Insulin in Type 2 Diabetes (MemAID) Clinical Trial.

Contemporary clinical trials·2022

Same author

Safety of Intranasal Insulin in Type 2 Diabetes on Systemic Insulin: A Double-Blinded Placebo-Controlled Sub-Study of Memaid Trial.

Archives of diabetes & obesity·2022

Same author

Mediterranean diet is inversely associated with steatosis and fibrosis and decreases ten-year diabetes and cardiovascular risk in NAFLD subjects: Results from the ATTICA prospective cohort study.

Clinical nutrition (Edinburgh, Scotland)·2020

Same author

Memory advancement by intranasal insulin in type 2 diabetes (MemAID) randomized controlled clinical trial: Design, methods and rationale.

Contemporary clinical trials·2020

Same author

Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials.

Diabetes & metabolism·2020

Area of Science:

Endocrinology
Urology
Epidemiology

Background:

Benign prostatic hyperplasia (BPH) is a common condition in aging men.
The endocrine factors contributing to BPH etiology require further investigation.

Purpose of the Study:

To investigate the potential endocrine etiology of benign prostatic hyperplasia (BPH).
To examine the association between specific hormone levels and BPH risk.

Main Methods:

A case-control study was conducted with 52 BPH patients and 52 age-matched healthy controls.
Blood samples were analyzed for testosterone, dihydrotestosterone, estradiol, sex hormone-binding globulin, and dehydroepiandrosterone sulfate (DHEAS).
Logistic regression models were used to analyze the association between hormone levels and BPH risk, adjusting for covariates.

Related Experiment Videos

Main Results:

Dehydroepiandrosterone sulfate (DHEAS) showed a significant positive association with BPH risk (odds ratio = 3.10 per standard deviation).
Testosterone (T) and estradiol (E2) levels were not found to be significantly related to BPH risk in this cohort.
The findings suggest a specific role for DHEAS in the development of BPH.

Conclusions:

Elevated dehydroepiandrosterone sulfate (DHEAS) may be a significant risk factor for developing benign prostatic hyperplasia (BPH).
Further research is warranted to elucidate the precise mechanisms linking DHEAS to BPH pathogenesis.